Expression of SGLT1 and SGLT2 in Breast Cancer and Potential Anticancer Effects of SGLT1 Inhibitors

被引：0
|
作者：
Tsunokake, Satoko [1 ]
Iwabichi, Erina [2 ]
Miki, Yasuhiro [3 ]
Kanai, Ayako [4 ]
Onodera, Yoshiaki [3 ]
Ishida, Takanori [1 ]
Sasano, Hironobu [3 ]
Suzuki, Takashi [2 ,3 ,5 ]
机构：
[1] Tohoku Univ, Dept Breast & Endocrine Surg Oncol, Sendai, Miyagi, Japan
[2] Tohoku Univ, Dept Pathol & Histotechnol, Sendai, Miyagi, Japan
[3] Tohoku Univ, Dept Anat Pathol, Sendai, Miyagi, Japan
[4] Hachinohe Municipal Hosp, Dept Breast Surg, Hachinohe, Aomori, Japan
[5] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3266
引用
收藏
页码：1939 / 1939
页数：1
相关论文
共 50 条
  • [1] Development of SGLT1 and SGLT2 inhibitors
    Rieg, Timo
    Vallon, Volker
    DIABETOLOGIA, 2018, 61 (10) : 2079 - 2086
  • [2] Development of SGLT1 and SGLT2 inhibitors
    Timo Rieg
    Volker Vallon
    Diabetologia, 2018, 61 : 2079 - 2086
  • [3] Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care
    Danne, Thomas
    Biester, Torben
    Kordonouri, Olga
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : 69 - 77
  • [4] Interacton of aromatic glucosides with SGLT1 and SGLT2
    Sampedro, AD
    Lostao, MP
    Hirayama, BA
    Wright, EM
    FASEB JOURNAL, 2000, 14 (04): : A348 - A348
  • [5] SGLT1 does compensate for SGLT2 inhibition
    Javier Martinez-Martin, Francisco
    Jimenez-Martin, Natalia
    Sablon-Gonzalez, Nery
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (04) : 256 - 256
  • [6] Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2
    Oranje, Paul
    Gouka, Robin
    Burggraaff, Lindsey
    Vermeer, Mario
    Chalet, Clement
    Duchateau, Guus
    van der Pijl, Pieter
    Geldof, Marian
    de Roo, Niels
    Clauwaert, Fenja
    Vanpaeschen, Toon
    Nicolai, Johan
    de Bruyn, Tom
    Annaert, Pieter
    IJzerman, Adriaan P.
    van Westen, Gerard J. P.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (04):
  • [7] SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice
    Spatola, Leonardo
    Finazzi, Silvia
    Angelini, Claudio
    Dauriz, Marco
    Badalamenti, Salvatore
    DIABETES THERAPY, 2018, 9 (01) : 427 - 430
  • [8] Effects of SGLT2 Inhibitors beyond Glycemic Control-Focus on Myocardial SGLT1
    Sayour, Alex Ali
    Ruppert, Mihaly
    Olah, Attila
    Benke, Kalman
    Barta, Balint Andras
    Zsary, Eszter
    Merkely, Bela
    Radovits, Tamas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [9] SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice
    Leonardo Spatola
    Silvia Finazzi
    Claudio Angelini
    Marco Dauriz
    Salvatore Badalamenti
    Diabetes Therapy, 2018, 9 : 427 - 430
  • [10] Improved glycemic control in mice lacking Sglt1 and Sglt2
    Powell, David R.
    DaCosta, Christopher M.
    Gay, Jason
    Ding, Zhi-Ming
    Smith, Melinda
    Greer, Jennifer
    Doree, Deon
    Jeter-Jones, Sabrina
    Mseeh, Faika
    Rodriguez, Lawrence A.
    Harris, Angela
    Buhring, Lindsey
    Platt, Kenneth A.
    Vogel, Peter
    Brommage, Robert
    Shadoan, Melanie K.
    Sands, Arthur T.
    Zambrowicz, Brian
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2013, 304 (02): : E117 - E130
12345